Our media

What does it take to turn world-class cancer research into innovations that reach patients?

In this episode of Labiotech's Beyond Biotech, our Chief Business Officer, Tony Hickson, speaks with host Dylan Kissane about translating promising science into new treatments, diagnostics and start-up companies.

The conversation explores what makes the Cancer Research Horizons model distinctive; the evolving relationship between charities, academia and industry; and how commercial success and patient benefit can go hand in hand. Tony also discusses C-Further, our childhood cancer consortium working to discover and develop new therapeutics designed specifically for the complex biology of childhood cancers.

July 2026

Our latest podcast is hosted by healthcare leader Parker Moss and delves into the life journeys of members of our world-class Expert Network, exploring the human stories and connections helping us drive cutting-edge science towards patient benefit. Parker follows the journeys that have shaped our experts’ careers and uncovers the latest breakthroughs in oncology, hard-won lessons in commercialisation, and the depth of the ecosystem needed to take discoveries all the way to life-changing treatment.

March 2025

The leap from the lab to generating a product can be daunting. This series aims to de-mystify the various routes you can take to translate your work, from the earliest steps to forming a start-up or licencing your work. 

You’ll meet technology-transfer experts, investors, patent attorneys, researchers – senior and early career – on their own translation journey and many more. Whether you want advice, other people’s translation tales or even a spot of inspiration… this series has something for you. 

22 January 2025

In the ‘Partnerships to beat cancer’ podcast, our Strategic Alliances team and guests from industry and academia delve into how we strike strategic alliances to fast-track the development of innovative cancer treatments.  

Episodes 1-5 are live now.

12 February 2024

Join Stuart Farrow, our VP of Bioscience, for an exclusive exploration into the dynamic realm of academic drug discovery and learn why target validation is crucial for academic drug discovery, and how to select the right target.

December 2024

A lot has changed in the global political landscape recently, leaving many of us to question - what will the impact on the life sciences sector be? This panel features insights from our Chief Business Officer, Tony Hickson. 

December 2024

How do you get the most from interactions with investors? In this panel moderated by Associate Director of Ventures Phil Masterson, features insights by Investor-in-Residence Jonathan Tobin. 

June 2023

Join Nikhil Gupta, Principal Scientist at Functional Genomics Centre (FGC), to find out how the FGC is leading the development and improvement of genetic screening tools, with the goal of accelerating the discovery of new cancer medicines.

April 2023

Join Steve Wedge, our Chief Scientific Officer and Mike Waring, our Head of Academic Medicinal Chemistry for this podcast with Drug Discovery World to find out how our Newcastle Drug Discovery site combines the strength of our enhanced drug discovery with that of our academic network. 

January 2023

Join Julie Little, Associate Director of our Strategic Alliances team, and Steve Wedge, Chief Scientific Officer of our Therapeutic Innovation arm to learn how we are leveraging alliances to bridge the translational gap between basic research and drug developments in the BTD Consulting Alliance Matters podcast.

Learn how our unique position helps us catalyse innovations in oncology, as well as the importance of de-risking drug discovery, and how you can work with us.

26-27 October 2022

Hear about "Extensive Sequence and Structural Evolution of Inhibitory Antibodies to Arginase2 Enabled by an Unbiased Approach to Affinity Maturation" from Stuart Haynes, Deputy Laboratory Head at the Antibody Alliance Laboratory. The talk was given as part of Technology Networks' "Advances in Drug Discovery and Development" symposium.

5 July 2022

Hear in our webinar how leading scientists at the Antibody Alliance Laboratory helped discover breakthrough therapies for cancer.

29-30 June 2022

Hear from Sofia Lourenco, our Principal Scientist, how our specialised, thematic alliances enable a deeper deconvolution across the multiple compartments present in the tumour microenvironment. The talk was given as part of Technology Networks' "The Landscape of Cancer Research" symposium.